WEHI-7326
Modify Date: 2025-08-25 10:04:32
WEHI-7326 structure
|
Common Name | WEHI-7326 | ||
|---|---|---|---|---|
| CAS Number | 1918966-87-6 | Molecular Weight | 463.502 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H25N9O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of WEHI-7326WEHI-7326 (WEHI 7326) is a specifi mitotic inhibitor and potential anticancer agent, causes cell cycle arrest in G2/M, cell death in vitro (MDA-MB-231 IC50=24.4 nM), and displays efficacious anti-tumor activity in vivo.WEHI-7326 induces cell death in a broad range of cancer cell lines, including taxane-resistant cells, and inhibits growth of human colon, brain, lung, prostate and breast tumors in mice xenografts.WEHI-7326 exceeded potency of myoseverin B by almost ten-fold, did not show any significant cytotoxic activity in vitro (IC50>40 uM) in HepG2 cells.WEHI-7326 prolongs survival in mouse models of high-risk neuroblastoma and leads to complete tumor regression when used in combination with standard-of-care relapse therapies. |
| Name | WEHI-7326 |
|---|
| Description | WEHI-7326 (WEHI 7326) is a specifi mitotic inhibitor and potential anticancer agent, causes cell cycle arrest in G2/M, cell death in vitro (MDA-MB-231 IC50=24.4 nM), and displays efficacious anti-tumor activity in vivo.WEHI-7326 induces cell death in a broad range of cancer cell lines, including taxane-resistant cells, and inhibits growth of human colon, brain, lung, prostate and breast tumors in mice xenografts.WEHI-7326 exceeded potency of myoseverin B by almost ten-fold, did not show any significant cytotoxic activity in vitro (IC50>40 uM) in HepG2 cells.WEHI-7326 prolongs survival in mouse models of high-risk neuroblastoma and leads to complete tumor regression when used in combination with standard-of-care relapse therapies. |
|---|---|
| References | 1. Christoph Grohmann, et al. Cell Death Dis. 2021 Mar 12;12(3):268. |
| Molecular Formula | C22H25N9O3 |
|---|---|
| Molecular Weight | 463.502 |